The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use. ...
Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease. ...